APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Attention-Deficit Hyperactivity Disorder Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Attention-Deficit Hyperactivity Disorder Treatment Industry Research Report 2026

27 December 2025118 pages

Choose your research edition.

Industry ResearchAttention-Deficit Hyperactivity Disorder Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Attention-Deficit Hyperactivity Disorder Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Attention-Deficit Hyperactivity Disorder Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Attention-Deficit Hyperactivity Disorder Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Attention-Deficit Hyperactivity Disorder Treatment Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Attention-Deficit Hyperactivity Disorder Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Attention-Deficit Hyperactivity Disorder Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Attention-Deficit Hyperactivity Disorder Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Attention-Deficit Hyperactivity Disorder Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Attention-Deficit Hyperactivity Disorder Treatment include The Takeda Pharmaceutical Company Limited, Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., Supernus Pharmaceutical,Inc., purdue Pharma L.P., Novartis AG, Neos Therapeutics Inc. and Mallinckrodt Pharmaceuticals and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Attention-Deficit Hyperactivity Disorder Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Attention-Deficit Hyperactivity Disorder Treatment.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Attention-Deficit Hyperactivity Disorder Treatment Market by Company

The Takeda Pharmaceutical Company Limited

Johnson & Johnson

Eli Lilly and Company

Pfizer Inc.

Supernus Pharmaceutical,Inc.

purdue Pharma L.P.

Novartis AG

Neos Therapeutics Inc.

Mallinckrodt Pharmaceuticals

Lupin Limited

Attention-Deficit Hyperactivity Disorder Treatment Segment by Type

Stimulants

Non-stimulants

Attention-Deficit Hyperactivity Disorder Treatment Segment by Application

Hospital

Clinic

Others

Attention-Deficit Hyperactivity Disorder Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Attention-Deficit Hyperactivity Disorder Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Attention-Deficit Hyperactivity Disorder Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Attention-Deficit Hyperactivity Disorder Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Attention-Deficit Hyperactivity Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Type (2021-2026) Table 7. Global Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Type (2027-2032) Table 9. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Application (2021-2026) Table 11. Global Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Application (2027-2032) Table 13. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Region (2021-2026) Table 16. Global Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Region (2027-2032) Table 18. Attention-Deficit Hyperactivity Disorder Treatment Industry Trends Table 19. Attention-Deficit Hyperactivity Disorder Treatment Industry Drivers Table 20. Attention-Deficit Hyperactivity Disorder Treatment Industry Opportunities and Challenges Table 21. Attention-Deficit Hyperactivity Disorder Treatment Market Restraints Table 22. Global Top Attention-Deficit Hyperactivity Disorder Treatment Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Players (2021-2026) Table 24. Global Attention-Deficit Hyperactivity Disorder Treatment Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Attention-Deficit Hyperactivity Disorder Treatment, Headquarters and Area Served Table 26. Global Attention-Deficit Hyperactivity Disorder Treatment Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Attention-Deficit Hyperactivity Disorder Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032) & (US$ Million) Table 45. The Takeda Pharmaceutical Company Limited Company Information Table 46. The Takeda Pharmaceutical Company Limited Business Overview Table 47. The Takeda Pharmaceutical Company Limited Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 48. The Takeda Pharmaceutical Company Limited Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 49. The Takeda Pharmaceutical Company Limited Recent Developments Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 53. Johnson & Johnson Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 54. Johnson & Johnson Recent Developments Table 55. Eli Lilly and Company Company Information Table 56. Eli Lilly and Company Business Overview Table 57. Eli Lilly and Company Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 58. Eli Lilly and Company Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 59. Eli Lilly and Company Recent Developments Table 60. Pfizer Inc. Company Information Table 61. Pfizer Inc. Business Overview Table 62. Pfizer Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 63. Pfizer Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 64. Pfizer Inc. Recent Developments Table 65. Supernus Pharmaceutical,Inc. Company Information Table 66. Supernus Pharmaceutical,Inc. Business Overview Table 67. Supernus Pharmaceutical,Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 68. Supernus Pharmaceutical,Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 69. Supernus Pharmaceutical,Inc. Recent Developments Table 70. purdue Pharma L.P. Company Information Table 71. purdue Pharma L.P. Business Overview Table 72. purdue Pharma L.P. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 73. purdue Pharma L.P. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 74. purdue Pharma L.P. Recent Developments Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 78. Novartis AG Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 79. Novartis AG Recent Developments Table 80. Neos Therapeutics Inc. Company Information Table 81. Neos Therapeutics Inc. Business Overview Table 82. Neos Therapeutics Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 83. Neos Therapeutics Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 84. Neos Therapeutics Inc. Recent Developments Table 85. Mallinckrodt Pharmaceuticals Company Information Table 86. Mallinckrodt Pharmaceuticals Business Overview Table 87. Mallinckrodt Pharmaceuticals Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 88. Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 89. Mallinckrodt Pharmaceuticals Recent Developments Table 90. Lupin Limited Company Information Table 91. Lupin Limited Business Overview Table 92. Lupin Limited Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) & (US$ Million) Table 93. Lupin Limited Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio Table 94. Lupin Limited Recent Developments Table 95. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Attention-Deficit Hyperactivity Disorder Treatment Product Image Figure 5. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Type: 2025 VS 2032 Figure 7. Stimulants Product Figure 8. Non-stimulants Product Figure 9. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Clinic Product Figure 13. Others Product Figure 14. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Attention-Deficit Hyperactivity Disorder Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Region: 2025 VS 2032 Figure 17. Global Attention-Deficit Hyperactivity Disorder Treatment Market Share by Players in 2025 Figure 18. Global Attention-Deficit Hyperactivity Disorder Treatment Manufacturers Established Date Figure 19. Global Top 5 and 10 Attention-Deficit Hyperactivity Disorder Treatment Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 23. United States Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 26. Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 28. Germany Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 38. China Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 43. Australia Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Attention-Deficit Hyperactivity Disorder Treatment Market Share by Country (2021-2032) Figure 48. Brazil Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Attention-Deficit Hyperactivity Disorder Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. The Takeda Pharmaceutical Company Limited Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 54. Johnson & Johnson Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 55. Eli Lilly and Company Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 56. Pfizer Inc. Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 57. Supernus Pharmaceutical,Inc. Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 58. purdue Pharma L.P. Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 59. Novartis AG Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 60. Neos Therapeutics Inc. Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 61. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026) Figure 62. Lupin Limited Revenue Growth Rate in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)

Scope & coverage.

Types
  • Stimulants
  • Non-stimulants
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • The Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • Eli Lilly and Company
  • Pfizer Inc.
  • Supernus Pharmaceutical,Inc.
  • purdue Pharma L.P.
  • Novartis AG
  • Neos Therapeutics Inc.
  • Mallinckrodt Pharmaceuticals
  • Lupin Limited

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Attention-Deficit Hyperactivity Disorder Treatment by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Stimulants
  5. 2.2.3 Non-stimulants
  6. 2.3 Attention-Deficit Hyperactivity Disorder Treatment by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Clinic
  10. 2.3.4 Others
  11. 2.4 Assumptions and Limitations
3 Attention-Deficit Hyperactivity Disorder Treatment Breakdown Data by Type
  1. 3.1 Global Attention-Deficit Hyperactivity Disorder Treatment Historic Market Size by Type (2021-2026)
  2. 3.2 Global Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Type (2027-2032)
4 Attention-Deficit Hyperactivity Disorder Treatment Breakdown Data by Application
  1. 4.1 Global Attention-Deficit Hyperactivity Disorder Treatment Historic Market Size by Application (2021-2026)
  2. 4.2 Global Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Attention-Deficit Hyperactivity Disorder Treatment Market Perspective (2021-2032)
  2. 5.2 Global Attention-Deficit Hyperactivity Disorder Treatment Growth Trends by Region
  3. 5.2.1 Global Attention-Deficit Hyperactivity Disorder Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Attention-Deficit Hyperactivity Disorder Treatment Historic Market Size by Region (2021-2026)
  5. 5.2.3 Attention-Deficit Hyperactivity Disorder Treatment Forecasted Market Size by Region (2027-2032)
  6. 5.3 Attention-Deficit Hyperactivity Disorder Treatment Market Dynamics
  7. 5.3.1 Attention-Deficit Hyperactivity Disorder Treatment Industry Trends
  8. 5.3.2 Attention-Deficit Hyperactivity Disorder Treatment Market Drivers
  9. 5.3.3 Attention-Deficit Hyperactivity Disorder Treatment Market Challenges
  10. 5.3.4 Attention-Deficit Hyperactivity Disorder Treatment Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Attention-Deficit Hyperactivity Disorder Treatment Players by Revenue
  2. 6.1.1 Global Top Attention-Deficit Hyperactivity Disorder Treatment Players by Revenue (2021-2026)
  3. 6.1.2 Global Attention-Deficit Hyperactivity Disorder Treatment Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Attention-Deficit Hyperactivity Disorder Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Attention-Deficit Hyperactivity Disorder Treatment Head Office and Area Served
  6. 6.4 Global Attention-Deficit Hyperactivity Disorder Treatment Players, Product Type & Application
  7. 6.5 Global Attention-Deficit Hyperactivity Disorder Treatment Manufacturers Established Date
  8. 6.6 Global Attention-Deficit Hyperactivity Disorder Treatment Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Attention-Deficit Hyperactivity Disorder Treatment Market Size (2021-2032)
  2. 7.2 North America Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026)
  4. 7.4 North America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size (2021-2032)
  2. 8.2 Europe Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026)
  4. 8.4 Europe Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size (2021-2032)
  2. 9.2 Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Attention-Deficit Hyperactivity Disorder Treatment Market Size (2021-2032)
  2. 10.2 South America Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026)
  4. 10.4 South America Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Size (2021-2032)
  2. 11.2 Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Attention-Deficit Hyperactivity Disorder Treatment Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 The Takeda Pharmaceutical Company Limited
  2. 12.1.1 The Takeda Pharmaceutical Company Limited Company Information
  3. 12.1.2 The Takeda Pharmaceutical Company Limited Business Overview
  4. 12.1.3 The Takeda Pharmaceutical Company Limited Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  5. 12.1.4 The Takeda Pharmaceutical Company Limited Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  6. 12.1.5 The Takeda Pharmaceutical Company Limited Recent Developments
  7. 12.2 Johnson & Johnson
  8. 12.2.1 Johnson & Johnson Company Information
  9. 12.2.2 Johnson & Johnson Business Overview
  10. 12.2.3 Johnson & Johnson Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  11. 12.2.4 Johnson & Johnson Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  12. 12.2.5 Johnson & Johnson Recent Developments
  13. 12.3 Eli Lilly and Company
  14. 12.3.1 Eli Lilly and Company Company Information
  15. 12.3.2 Eli Lilly and Company Business Overview
  16. 12.3.3 Eli Lilly and Company Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  17. 12.3.4 Eli Lilly and Company Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  18. 12.3.5 Eli Lilly and Company Recent Developments
  19. 12.4 Pfizer Inc.
  20. 12.4.1 Pfizer Inc. Company Information
  21. 12.4.2 Pfizer Inc. Business Overview
  22. 12.4.3 Pfizer Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  23. 12.4.4 Pfizer Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  24. 12.4.5 Pfizer Inc. Recent Developments
  25. 12.5 Supernus Pharmaceutical,Inc.
  26. 12.5.1 Supernus Pharmaceutical,Inc. Company Information
  27. 12.5.2 Supernus Pharmaceutical,Inc. Business Overview
  28. 12.5.3 Supernus Pharmaceutical,Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  29. 12.5.4 Supernus Pharmaceutical,Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  30. 12.5.5 Supernus Pharmaceutical,Inc. Recent Developments
  31. 12.6 purdue Pharma L.P.
  32. 12.6.1 purdue Pharma L.P. Company Information
  33. 12.6.2 purdue Pharma L.P. Business Overview
  34. 12.6.3 purdue Pharma L.P. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  35. 12.6.4 purdue Pharma L.P. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  36. 12.6.5 purdue Pharma L.P. Recent Developments
  37. 12.7 Novartis AG
  38. 12.7.1 Novartis AG Company Information
  39. 12.7.2 Novartis AG Business Overview
  40. 12.7.3 Novartis AG Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  41. 12.7.4 Novartis AG Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  42. 12.7.5 Novartis AG Recent Developments
  43. 12.8 Neos Therapeutics Inc.
  44. 12.8.1 Neos Therapeutics Inc. Company Information
  45. 12.8.2 Neos Therapeutics Inc. Business Overview
  46. 12.8.3 Neos Therapeutics Inc. Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  47. 12.8.4 Neos Therapeutics Inc. Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  48. 12.8.5 Neos Therapeutics Inc. Recent Developments
  49. 12.9 Mallinckrodt Pharmaceuticals
  50. 12.9.1 Mallinckrodt Pharmaceuticals Company Information
  51. 12.9.2 Mallinckrodt Pharmaceuticals Business Overview
  52. 12.9.3 Mallinckrodt Pharmaceuticals Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  53. 12.9.4 Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  54. 12.9.5 Mallinckrodt Pharmaceuticals Recent Developments
  55. 12.10 Lupin Limited
  56. 12.10.1 Lupin Limited Company Information
  57. 12.10.2 Lupin Limited Business Overview
  58. 12.10.3 Lupin Limited Revenue in Attention-Deficit Hyperactivity Disorder Treatment Business (2021-2026)
  59. 12.10.4 Lupin Limited Attention-Deficit Hyperactivity Disorder Treatment Product Portfolio
  60. 12.10.5 Lupin Limited Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst